Hepatitis A Hospitalization Costs, United States, 2017

The United States is in the midst of unprecedented person-to-person hepatitis A outbreaks. By using Healthcare Cost and Utilization Project data, we estimated the average costs per hepatitis A–related hospitalization in 2017. These estimates can guide investment in outbreak prevention efforts to sto...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofmeister, Megan G., Yin, Shaoman, Aslam, Maria V., Teshale, Eyasu H., Spradling, Philip R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181923/
https://www.ncbi.nlm.nih.gov/pubmed/32310068
http://dx.doi.org/10.3201/eid2605.191224
_version_ 1783526148491182080
author Hofmeister, Megan G.
Yin, Shaoman
Aslam, Maria V.
Teshale, Eyasu H.
Spradling, Philip R.
author_facet Hofmeister, Megan G.
Yin, Shaoman
Aslam, Maria V.
Teshale, Eyasu H.
Spradling, Philip R.
author_sort Hofmeister, Megan G.
collection PubMed
description The United States is in the midst of unprecedented person-to-person hepatitis A outbreaks. By using Healthcare Cost and Utilization Project data, we estimated the average costs per hepatitis A–related hospitalization in 2017. These estimates can guide investment in outbreak prevention efforts to stop the spread of this vaccine-preventable disease.
format Online
Article
Text
id pubmed-7181923
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-71819232020-05-06 Hepatitis A Hospitalization Costs, United States, 2017 Hofmeister, Megan G. Yin, Shaoman Aslam, Maria V. Teshale, Eyasu H. Spradling, Philip R. Emerg Infect Dis Research Letter The United States is in the midst of unprecedented person-to-person hepatitis A outbreaks. By using Healthcare Cost and Utilization Project data, we estimated the average costs per hepatitis A–related hospitalization in 2017. These estimates can guide investment in outbreak prevention efforts to stop the spread of this vaccine-preventable disease. Centers for Disease Control and Prevention 2020-05 /pmc/articles/PMC7181923/ /pubmed/32310068 http://dx.doi.org/10.3201/eid2605.191224 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Letter
Hofmeister, Megan G.
Yin, Shaoman
Aslam, Maria V.
Teshale, Eyasu H.
Spradling, Philip R.
Hepatitis A Hospitalization Costs, United States, 2017
title Hepatitis A Hospitalization Costs, United States, 2017
title_full Hepatitis A Hospitalization Costs, United States, 2017
title_fullStr Hepatitis A Hospitalization Costs, United States, 2017
title_full_unstemmed Hepatitis A Hospitalization Costs, United States, 2017
title_short Hepatitis A Hospitalization Costs, United States, 2017
title_sort hepatitis a hospitalization costs, united states, 2017
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181923/
https://www.ncbi.nlm.nih.gov/pubmed/32310068
http://dx.doi.org/10.3201/eid2605.191224
work_keys_str_mv AT hofmeistermegang hepatitisahospitalizationcostsunitedstates2017
AT yinshaoman hepatitisahospitalizationcostsunitedstates2017
AT aslammariav hepatitisahospitalizationcostsunitedstates2017
AT teshaleeyasuh hepatitisahospitalizationcostsunitedstates2017
AT spradlingphilipr hepatitisahospitalizationcostsunitedstates2017

Ejemplares similares